Abstract
This is a review of the epidemiology and management of infectious complications in contemporary management of chronic leukemias. Patients with chronic leukemias typically are affected by nuisance infections due to the underlying hematologic condition, particularly hypogammaglobulinemia in CLL patients. With active treatment, particularly those agents that cause defects in cell-mediated immunity, the incidence of opportunistic infections increases although endogenous bacterial, mycobacterial, and fungal infections also occur. Exogenous treatment with immunoglobulin and antimicrobial prophylaxis, particularly anti-Pneumocystis prophylaxis, may be indicated in select patients. Routine vaccinations should be maintained in these patients and vaccination early in the course of treatment may result in improve protection.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3-10 |
| Number of pages | 8 |
| Journal | Infectious Disorders - Drug Targets |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chronic granulocytic leukemia (CGL)
- Chronic lymphoid leukemia (CLL)
- Chronic myelogenous leukemia (CML)
- Hypogammaglobulinemia
- Opportunistic infection
- Pneumocystis
Fingerprint
Dive into the research topics of 'Epidemiology and management of infectious complications in contemporary management of chronic leukemias'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS